CN Patent

CN119185298B — 帕罗伐汀在制备用于治疗脑出血后急性脑损伤的药物中的应用

Assigned to Renmin Hospital of Wuhan University · Expires 2025-09-26 · 1y expired

What this patent protects

本发明提供了帕罗伐汀在制备用于治疗脑出血后急性脑损伤的药物中的应用。本发明首次发现帕罗伐汀能够减少脑出血后神经元死亡及炎症、能改善SAH小鼠神经功能损伤和脑水肿、能减少SAH小鼠神经损伤及炎症。帕罗伐汀在制备用于治疗脑出血后急性脑损伤的药物中具有极大的应用前景。

USPTO Abstract

本发明提供了帕罗伐汀在制备用于治疗脑出血后急性脑损伤的药物中的应用。本发明首次发现帕罗伐汀能够减少脑出血后神经元死亡及炎症、能改善SAH小鼠神经功能损伤和脑水肿、能减少SAH小鼠神经损伤及炎症。帕罗伐汀在制备用于治疗脑出血后急性脑损伤的药物中具有极大的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN119185298B
Jurisdiction
CN
Classification
—
Expires
2025-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Renmin Hospital of Wuhan University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.